Artivion (AORT) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.54% |
| Dec 31, 2025 | 10.40% |
| Sep 30, 2025 | 11.52% |
| Jun 30, 2025 | 15.29% |
| Mar 31, 2025 | 7.56% |
| Dec 31, 2024 | 5.73% |
| Sep 30, 2024 | 6.17% |
| Jun 30, 2024 | 6.16% |
| Mar 31, 2024 | 7.29% |
| Dec 31, 2023 | 6.22% |
| Sep 30, 2023 | 5.67% |
| Jun 30, 2023 | 4.84% |
| Mar 31, 2023 | 6.49% |
| Dec 31, 2022 | 6.95% |
| Sep 30, 2022 | 10.30% |
| Jun 30, 2022 | 9.66% |
| Mar 31, 2022 | 11.44% |
| Dec 31, 2021 | 10.49% |
| Sep 30, 2021 | 9.92% |
| Jun 30, 2021 | 10.76% |
| Mar 31, 2021 | 11.61% |
| Dec 31, 2020 | 10.96% |
| Sep 30, 2020 | 13.42% |
| Jun 30, 2020 | 10.74% |
| Mar 31, 2020 | 17.57% |
| Dec 31, 2019 | 15.51% |
| Sep 30, 2019 | 13.70% |
| Jun 30, 2019 | 15.98% |
| Mar 31, 2019 | 14.52% |
| Dec 31, 2018 | 15.19% |
| Sep 30, 2018 | 12.84% |
| Jun 30, 2018 | 16.38% |
| Mar 31, 2018 | 11.00% |
| Dec 31, 2017 | 11.56% |
| Sep 30, 2017 | 6.98% |
| Jun 30, 2017 | 9.02% |
| Mar 31, 2017 | 6.75% |
| Dec 31, 2016 | 9.99% |
| Sep 30, 2016 | 9.51% |
| Jun 30, 2016 | 9.72% |
| Mar 31, 2016 | 8.34% |
| Dec 31, 2015 | 8.56% |
| Sep 30, 2015 | 8.59% |
| Jun 30, 2015 | 3.94% |